Atlas Trials

Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer

Clinical trial NCT00568529 · SUSPENDED

Trial details

NCT number
NCT00568529
Sponsor
Fudan University
Status
SUSPENDED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Cancer
Start date
2007-10-01
Primary completion
2009-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.